Symptoms of Human Papillomavirus (HPV) in Women

Nov 22, 2021 Source: Cainiu Health
Dr. Wu Xuehui
Introduction
Human papillomavirus (HPV) infection, commonly referred to as HPV infection in clinical practice, is categorized into high-risk and low-risk types. High-risk HPV infections are typically asymptomatic in clinical settings. In contrast, low-risk HPV infections may cause genital warts, which clinically manifest as cauliflower-like growths on the vulvar or vaginal mucosa or on the cervix.

Human papillomavirus (HPV) primarily affects the skin and mucous membranes; thus, symptoms vary depending on the anatomical site of infection. Understanding these symptoms is therefore essential. Below, we detail the manifestations of HPV infection in women.

Symptoms of HPV Infection in Women

Clinically, human papillomavirus infection is commonly referred to as HPV infection. HPV infections are further classified into high-risk and low-risk types. High-risk HPV infections often produce no noticeable symptoms but can cause cervical epithelial abnormalities and even progress to cervical cancer. Therefore, annual HPV screening is strongly recommended. In contrast, low-risk HPV infections—particularly those caused by HPV types 6 and 11—commonly result in genital warts (condyloma acuminatum). Clinically categorized as a sexually transmitted infection (STI), this condition is primarily transmitted through sexual contact. Characteristic cauliflower-like growths may appear on the vulva, vaginal mucosa, or cervix. Clinical management typically includes interventions such as laser ablation or surgical excision. Patients frequently report pruritus (itching) of the vulva.

Knowledge Extension: How Is HPV Treated?

1. Physical Therapies

These modalities aim to remove visible lesions as well as subclinical infections. Options include cryotherapy, microwave therapy, laser ablation, electrocautery, surgical excision, and photodynamic therapy.

2. Pharmacological Treatment

Specific antiviral medications can effectively alleviate HPV-related conditions. Clinically proven agents include 0.5% podophyllotoxin tincture and 5% imiquimod cream—both widely recognized as first-line topical treatments for HPV. Additionally, immunomodulatory agents such as interferon and interleukins may be employed to enhance host immune responses against the virus.

3. Immunotherapy

Immunotherapeutic approaches help reduce recurrence rates and accelerate lesion clearance. Examples include autologous vaccines, interferon, and bacillus Calmette–Guérin (BCG) vaccine.

The above outlines the key clinical manifestations of HPV infection in women. We hope this information proves helpful to you.

Related Articles

View All